Clinical Trials Directory

Trials / Unknown

UnknownNCT00100061

Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)

Dose Response to Cranberry of Women With Recurrent UTIs

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
Female
Age
19 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the role of cranberry-containing products in preventing urinary tract infections (UTIs).

Detailed description

Although cranberry-containing products are commonly taken to prevent UTIs and other urinary symptoms, an optimally effective dose has not been established, and the chemicals responsible for the UTI-preventing properties in cranberry-containing products have yet to be determined. This study will determine the minimum dose of cranberry-containing product necessary to prevent UTIs, the effectiveness of cranberry-containing products in fighting different strains of E. coli, and the long-term effects of cranberry-containing product consumption. This study will also determine whether plant pigments called proanthocyanidins influence the UTI-preventing properties of cranberry-containing products. This study will last 2 years. Participants will be randomly assigned to receive varying doses of either cranberry-containing products or placebo for 1 year. Some participants will receive cranberry or placebo supplement tablets; others will receive cranberry juice or a placebo beverage. Clinic visits will occur every 2 months; urine collection will occur at each visit. Some participants will be asked to collect 24-hour urine samples every 8 weeks and provide urine samples on Days 1, 3, 5 and 7. Laboratory tests will be used to assess participants during the study. A 3-day course of antibiotics will be provided to participants developing a UTI during the course of the study. Telephone interview follow-up at 6 and 12 months after the study will determine whether cranberry-containing product use has continued and whether UTIs have recurred.

Conditions

Interventions

TypeNameDescription
DRUGCranberry juiceliquid juice taken daily
DIETARY_SUPPLEMENTCranberry JuiceTaken orally
DIETARY_SUPPLEMENTPlacebo cranberry juicePlacebo comparitor

Timeline

Start date
2007-05-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2004-12-23
Last updated
2013-03-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00100061. Inclusion in this directory is not an endorsement.